Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Berlan

Showing results (71-80 of 141) with videos related to

Pageof 15
Sort By:
The Journal of Clinical Investigation|January 1, 1990
Neuropeptide Y and peptide YY inhibit lipolysis in human and dog fat cells through a pertussis toxin-sensitive G proteinP Valet, M Berlan, M Beauville, et al.
British Journal of Pharmacology|December 24, 1997
Lipolytic effects of conventional beta 3-adrenoceptor agonists and of CGP 12,177 in rat and human fat cells: preliminary pharmacological evidence for a putative beta 4-adrenoceptorJ Galitzky, D Langin, P Verwaerde, et al.
British Journal of Clinical Pharmacology|January 1, 1994
Pharmacokinetic study of yohimbine and its pharmacodynamic effects on salivary secretion in patients treated with tricyclic antidepressantsH Bagheri, P Picault, L Schmitt, et al.
Annales D'Endocrinologie|January 1, 1995
[Lipid mobilization, physiopathological and pharmacological aspects]M Berlan, P Barbe, V Stich, et al.
British Journal of Pharmacology|May 1, 1989
Lipomobilizing effects of procaterol and yohimbine in the conscious dog: comparison of endocrinological, metabolic and cardiovascular effectsP Valet, M Taouis, M A Tran, et al.
Journal of Lipid Research|January 1, 1996
Expression of beta3-adrenoceptors with low lipolytic action in human subcutaneous white adipocytesG Tavernier, P Barbe, J Galitzky, et al.
International Journal of Obesity|January 1, 1989
Platelet alpha 2-adrenoceptors and adrenergic adipose tissue responsiveness after moderate hypocaloric diet in obese subjectsF Crampes, M Marceron, M Beauville, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1989
Differential regulation of fat cell beta-2 and beta-1 adrenoceptors by endogenous catecholamines in dogP Valet, J L Montastruc, M Berlan, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 1, 1989
Lipolytic action of a new alpha-2 adrenergic antagonist of the piperazinopyrimidine family: RP 55462J S Saulnier-Blache, M Taouis, M Dauzats, et al.
The Journal of Clinical Endocrinology and Metabolism|January 1, 1997
In vivo increase in beta-adrenergic lipolytic response in subcutaneous adipose tissue of obese subjects submitted to a hypocaloric dietP Barbe, V Stich, J Galitzky, et al.
Pageof 15

Showing results (71-80 of 141) with videos related to

Sort By:
Pageof 15
The Journal of Clinical Investigation|January 1, 1990
Neuropeptide Y and peptide YY inhibit lipolysis in human and dog fat cells through a pertussis toxin-sensitive G proteinP Valet, M Berlan, M Beauville, et al.
British Journal of Pharmacology|December 24, 1997
Lipolytic effects of conventional beta 3-adrenoceptor agonists and of CGP 12,177 in rat and human fat cells: preliminary pharmacological evidence for a putative beta 4-adrenoceptorJ Galitzky, D Langin, P Verwaerde, et al.
British Journal of Clinical Pharmacology|January 1, 1994
Pharmacokinetic study of yohimbine and its pharmacodynamic effects on salivary secretion in patients treated with tricyclic antidepressantsH Bagheri, P Picault, L Schmitt, et al.
Annales D'Endocrinologie|January 1, 1995
[Lipid mobilization, physiopathological and pharmacological aspects]M Berlan, P Barbe, V Stich, et al.
British Journal of Pharmacology|May 1, 1989
Lipomobilizing effects of procaterol and yohimbine in the conscious dog: comparison of endocrinological, metabolic and cardiovascular effectsP Valet, M Taouis, M A Tran, et al.
Journal of Lipid Research|January 1, 1996
Expression of beta3-adrenoceptors with low lipolytic action in human subcutaneous white adipocytesG Tavernier, P Barbe, J Galitzky, et al.
International Journal of Obesity|January 1, 1989
Platelet alpha 2-adrenoceptors and adrenergic adipose tissue responsiveness after moderate hypocaloric diet in obese subjectsF Crampes, M Marceron, M Beauville, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1989
Differential regulation of fat cell beta-2 and beta-1 adrenoceptors by endogenous catecholamines in dogP Valet, J L Montastruc, M Berlan, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 1, 1989
Lipolytic action of a new alpha-2 adrenergic antagonist of the piperazinopyrimidine family: RP 55462J S Saulnier-Blache, M Taouis, M Dauzats, et al.
The Journal of Clinical Endocrinology and Metabolism|January 1, 1997
In vivo increase in beta-adrenergic lipolytic response in subcutaneous adipose tissue of obese subjects submitted to a hypocaloric dietP Barbe, V Stich, J Galitzky, et al.
Pageof 15